We are live on
!
Find out more
Kiniksa Pharmaceuticals
KNSA
KNSA
104 hedge funds and large institutions have $537M invested in Kiniksa Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 38 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
2% more capital invested
Capital invested by funds: $526M → $537M (+$11.4M)
3.12% less ownership
Funds ownership: 94.09% → 90.98% (-3.1%)
4% less funds holding
Funds holding: 108 → 104 (-4)
13% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 38
18% less call options, than puts
Call options by funds: $4.96M | Put options by funds: $6.08M
19% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 21
Holders
104
Holders Change
-4
Holders Change %
-3.7%
% of All Funds
1.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
33
Reduced
38
Closed
21
Calls
$4.96M
Puts
$6.08M
Net Calls
-$1.12M
Net Calls Change
-$1.99M
Top Buyers
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$20.5M |
| 2 |
Barclays
London,
United Kingdom
|
-$8.7M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$6.89M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$5.85M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$5.22M |
